Skip to main content

Table 3 Investigatorsa in the Pregabalin Adolescent Fibromyalgia Study Group

From: Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension study

Investigator

Institution

Anthony Alario

University of Massachusetts Memorial Medical Center, Worcester, MA, United States

Sushrut Sudhir Babhulkar

Sushrut Hospital, Research Centre & Post Graduate Institute of Orthopedics, Nagpur, India

Ramon Berenguer

Florida Medical Center & Research, Inc., Miami, FL, United States

Pamela Freeman

Rheumatology Associates of Central Florida, Orlando, FL, United States

Jeffrey Gold

Children’s Hospital Los Angeles, Los Angeles, CA, United States

Steven Goodman

Delray Research Associates, Delray Beach, FL, United States

Hana Jarosova

Bioregeneracni a rehabilitacni centrum, Ricany, Czech Republic

Wendy Lee

South Carolina Research Center, Myrtle Beach, SC, United States

Jonathan Liss

Medical Research & Health Education Foundation, Inc. Columbus, GA, United States

Svetlana Lvovich

St. Christopher's Hospital for Children, Philadelphia, PA, United States

Adonis Maiquez

Harmony Clinical Research Inc., North Miami Beach, FL, United States

Nabil Morcos

Apex Research Institute, Santa Ana, CA, United States

Shankara Nellikunja

Mallikatta Neuro Centre, Mangalore, India

Murray Passo

Medical University of South Carolina, Charleston, SC, United States

Laura Schanberg

Duke University Medical Center, Durham, NC, United States

Vijai Prakash Sharma

King George’s Medical University, Lucknow, India

Charles Spencer

Nationwide Children's Hospital, Columbus, OH, United States

Mary Toth

Akron Children's Hospital, Akron, OH, United States

Sarath Chandra Mouli Veeravalli

Krishna Institute of Medical Sciences Ltd, Secunderabad, India

Wen-Chin Weng

National Taiwan University Hospital, Taipei, Taiwan

  1. a Investigators listed in alphabetical order by last name